Alexander Alexiev is CEO of SAT Health. He has more than 15 years of experience in the pharmaceutical industry. In the past 10 years he’s also been part of one of the largest analytics companies. He graduated with Technical Management degree from the University of Stuttgart. He holds a diploma from the Faculty of Economics at Sofia University of Business Administration.Since 2017 his work is dedicated to the start up company SAT Health. SAT Health is a certified provider of information and technology solutions to the pharmaceutical industry, analysis based on data from clinical practice and patient programs.
UK
Mark Lawler, Prof.
Associate Pro-Vice-Chancellor, Professor of Digital Health, and Chair in Translational Cancer Genomics
Queen's University Belfast (QUB)
